scholarly article | Q13442814 |
P2093 | author name string | Schmidt C | |
Reutter W | |||
Stehling P | |||
Horstkorte R | |||
Schnitzer J | |||
P2860 | cites work | Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor | Q24561804 |
Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis | Q28239786 | ||
CD9 of mouse brain is implicated in neurite outgrowth and cell migration in vitro and is associated with the alpha 6/beta 1 integrin and the neural adhesion molecule L1 | Q28292038 | ||
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue | Q29615225 | ||
Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells | Q33751730 | ||
Chemistry, metabolism, and biological functions of sialic acids. | Q34268689 | ||
Diversity in the sialic acids | Q35930370 | ||
The mechanism by which microorganisms avoid complement attack | Q36166659 | ||
Transplantation of oligodendrocyte precursors in the adult demyelinated spinal cord: migration and remyelination | Q36743106 | ||
Glial cell lineage in the cerebral cortex: A review and synthesis | Q37085600 | ||
Growth of a rat neuroblastoma cell line in serum-free supplemented medium | Q37313160 | ||
Differentiation signals in the CNS: type-2 astrocyte development in vitro as a model system | Q37946492 | ||
Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation | Q38334824 | ||
Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity | Q40838879 | ||
Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts | Q41588231 | ||
Incorporation of N-acyl-2-amino-2-deoxy-hexoses into glycosphingolipids of the pheochromocytoma cell line PC 12 | Q41628437 | ||
Biosynthetic modulation of sialic acid-dependent virus-receptor interactions of two primate polyoma viruses | Q45784354 | ||
Monoclonal antibody A2B5 reacts with many gangliosides in neuronal tissue | Q48626780 | ||
Anti-ganglioside antibodies reveal subsets of cultured rat dorsal root ganglion neurons | Q48880008 | ||
Turnover studies of the neural cell adhesion molecule NCAM: degradation of NCAM in PC12 cells depends on the presence of NGF. | Q52999994 | ||
Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor ceil | Q59093382 | ||
Fluorometric high-performance liquid chromatography of N-acetyl- and N-glycolylneuraminic acids and its application to their microdetermination in human and animal sera, glycoproteins, and glycolipids | Q69437666 | ||
In vivo modulated N-acyl side chain of N-acetylneuraminic acid modulates the cell contact-dependent inhibition of growth | Q71738569 | ||
Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H | Q72733127 | ||
P433 | issue | 30 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 19146-19152 | |
P577 | publication date | 1998-07-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Biochemical engineering of neural cell surfaces by the synthetic N-propanoyl-substituted neuraminic acid precursor | |
P478 | volume | 273 |
Q38538715 | Accessibility of N-acyl-D-mannosamines to N-acetyl-D-neuraminic acid aldolase |
Q33519629 | Advances in the biology and chemistry of sialic acids |
Q30864986 | Biochemical engineering of cell surface sialic acids stimulates axonal growth. |
Q44997402 | Biochemical engineering of the N-acyl side chain of sialic acid leads to increased calcium influx from intracellular compartments and promotes differentiation of HL60 cells |
Q39250748 | Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid. |
Q55287163 | Biomimetic neural scaffolds: a crucial step towards optimal peripheral nerve regeneration. |
Q24629024 | Bioorthogonal chemistry: fishing for selectivity in a sea of functionality |
Q43654999 | Biosynthetic incorporation of unnatural sialic acids into polysialic acid on neural cells |
Q34545778 | Carbohydrate engineered cells for regenerative medicine. |
Q34425124 | Chemical and biological strategies for engineering cell surface glycosylation |
Q34522697 | Chemical approaches to the investigation of cellular systems |
Q36811051 | Chemical probing of glycans in cells and organisms |
Q43851400 | Differential effects of unnatural sialic acids on the polysialylation of the neural cell adhesion molecule and neuronal behavior |
Q40785091 | Efficient biochemical engineering of cellular sialic acids using an unphysiological sialic acid precursor in cells lacking UDP-N-acetylglucosamine 2-epimerase |
Q36166263 | Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell |
Q40343581 | Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine |
Q47172587 | Experimental Design Considerations for In Vitro Non-Natural Glycan Display via Metabolic Oligosaccharide Engineering. |
Q91503235 | Exploiting metabolic glycoengineering to advance healthcare |
Q90222396 | Exploration of the Sialic Acid World |
Q43105217 | Fluorination of mammalian cell surfaces via the sialic acid biosynthetic pathway. |
Q38715644 | Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid. |
Q27027997 | Glycotherapy: new advances inspire a reemergence of glycans in medicine |
Q34573479 | Hexosamine analogs: from metabolic glycoengineering to drug discovery. |
Q59132146 | Improving Immunotherapy Through Glycodesign |
Q53554546 | In vivo stimulation of early peripheral axon regeneration by N-propionylmannosamine in the presence of polysialyltransferase ST8SIA2. |
Q74127924 | Incorporation of N-propanoylneuraminic acid leads to calcium oscillations in oligodendrocytes upon the application of GABA |
Q44849043 | Increased expression of the selectin ligand sialyl-Lewis(x) by biochemical engineering of sialic acids |
Q39607052 | Invasion of Trypanosoma cruzi into host cells is impaired by N-propionylmannosamine and other N-acylmannosamines |
Q42274779 | Investigating infection processes with a workflow from organic chemistry to biophysics: the combination of metabolic glycoengineering, super-resolution fluorescence imaging and proteomics. |
Q49498172 | Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines |
Q38902441 | Metabolic Glycoengineering with N-Acyl Side Chain Modified Mannosamines |
Q38634704 | Metabolic Remodeling of Cell-Surface Sialic Acids: Principles, Applications, and Recent Advances |
Q36964235 | Metabolic glycoengineering of mesenchymal stromal cells with N-propanoylmannosamine |
Q37405391 | Metabolic glycoengineering: sialic acid and beyond |
Q39367521 | Metabolic monosaccharides altered cell responses to anticancer drugs |
Q37950862 | Metabolic oligosaccharide engineering: implications for selectin-mediated adhesion and leukocyte extravasation. |
Q35165149 | Modified GM3 gangliosides produced by metabolic oligosaccharide engineering |
Q41147185 | N-Propionylmannosamine stimulates axonal elongation in a murine model of sciatic nerve injury |
Q45964578 | Photocrosslinking of glycoconjugates using metabolically incorporated diazirine-containing sugars. |
Q35228550 | Preparation and immunological studies of protein conjugates of N -acylneuraminic acids |
Q37993590 | Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies |
Q42631024 | Selective inhibition of polysialyltransferase ST8SiaII by unnatural sialic acids |
Q46785659 | Sialic acid metabolism is involved in the regulation of gene expression during neuronal differentiation of PC12 cells |
Q50867913 | Stimulation of human peripheral blood mononuclear cells by the sialic acid precursor N-propanoylmannosamine. |
Q35234194 | Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines |
Q37152815 | The chemical neurobiology of carbohydrates |
Q35031519 | Tissue-based metabolic labeling of polysialic acids in living primary hippocampal neurons |
Search more.